Category Archives: Alternative Medicine

Dataintelo.com, has added the latest research on AYUSH and Alternative Medicine Market, which offers a concise outline of the market valuation, industry size, SWOT analysis, revenue approximation, and the regional outlook of this business vertical. The report precisely features the key opportunities and challenges faced by contenders of this industry and presents the existing competitive setting and corporate strategies enforced by the AYUSH and Alternative Medicine Market players.

As per the AYUSH and Alternative Medicine Market report, this industry is predicted to grow substantial returns by the end of the forecast duration, recording a profitable yearly growth in the upcoming years. Shedding light on brief of this industry, the report offers considerable details concerning complete valuation of the market as well as detailed analysis of the AYUSH and Alternative Medicine Market along with existing growth opportunities in the business vertical.

Request a sample Report of AYUSH and Alternative Medicine Market at: https://dataintelo.com/request-sample/?reportId=94639

Concepts and ideas in the report:Analysis of the region- based segment in the AYUSH and Alternative Medicine Market: As per the report, in terms of provincial scope, the AYUSH and Alternative Medicine Market is divided into USA, Europe, Japan, China, India and South East Asia. It also includes particulars related to the products usage throughout the geographical landscape. Data related to the evaluations held by all the zones mentioned as well as the market share registered by each region is included in the report. Sum of all the product consumption growth rate across the applicable regions as well as consumption market share is described in the report. The report speaks about consumption rate of all regions, based on product types and applications.

Brief of the market segmentation: As per the product type, the AYUSH and Alternative Medicine Market is categorized intoAyurvedic MedicinesHerbal MedicinesAroma TherapyHomeopathyReflexologyOthers

Furthermore, the market share of each product along with the project valuation is mentioned in the report. The report consists of facts related to every single products sale price, revenue, growth rate over the estimation time period.

The AYUSH and Alternative Medicine Market, according to the application spectrum, is categorized intoWomenMenKids

Data pertaining the market share of each product application as well as estimated revenue that each application registers for is slated in the report.

Propelling factors & challenges: The report provides data concerning the forces influencing the commercialization scale of the AYUSH and Alternative Medicine Market and their effect on the revenue graph of this business vertical. Data pertaining to latest trends driving the AYUSH and Alternative Medicine Market along with the challenges this industry is about to experience in the upcoming years is mentioned in the report.

Ask for Discount on AYUSH and Alternative Medicine Market Report at: https://dataintelo.com/ask-for-discount/?reportId=94639

Implementing marketing tactics: Ideas about numerous marketing strategies implemented by the renowned shareholders with respect to product marketing is present in the report. Information related to the sales channels that companies select is also included in the report. Along with the dealers of these products, it also presents the summary of the top customers for the same.

Analysis of the major competitors in the market:An outline of the manufacturers active in the AYUSH and Alternative Medicine Market, consisting ofBaidyanathHimalya HerbalsGanga PharmaceuticalsPatanjaliHamdardalong with the distribution limits and sales area is reported. Particulars of each competitor including company profile, overview, as well as their range of products is inculcated in the report. The report also gives importance to product sales, price models, gross margins, and revenue generations. The AYUSH and Alternative Medicine Market report consists of details such as estimation of the geographical landscape, study related to the market concentration rate as well as concentration ratio over the estimated time period.

To Buy this report, Visit : https://dataintelo.com/checkout/?reportId=94639

Some of the Major Highlights of TOC covers:AYUSH and Alternative Medicine Regional Market Analysis AYUSH and Alternative Medicine Production by Regions Global AYUSH and Alternative Medicine Production by Regions Global AYUSH and Alternative Medicine Revenue by Regions AYUSH and Alternative Medicine Consumption by Regions

AYUSH and Alternative Medicine Segment Market Analysis (by Type) Global AYUSH and Alternative Medicine Production by Type Global AYUSH and Alternative Medicine Revenue by Type AYUSH and Alternative Medicine Price by Type

AYUSH and Alternative Medicine Segment Market Analysis (by Application) Global AYUSH and Alternative Medicine Consumption by Application Global AYUSH and Alternative Medicine Consumption Market Share by Application (2014-2019)

AYUSH and Alternative Medicine Major Manufacturers Analysis AYUSH and Alternative Medicine Production Sites and Area Served Product Introduction, Application and Specification AYUSH and Alternative Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) Main Business and Markets Served

For More Information on this report, Request Inquiry At https://dataintelo.com/enquiry-before-buying/?reportId=94639

About DataIntelo: DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info DataIntelo Name Alex Mathews Email [emailprotected] Website https://dataintelo.com Address 500 East E Street, Ontario, CA 91764, United States.

Read the original post:

Global AYUSH and Alternative Medicine Market Business Analysis 2019 by CAGR, Share, Revenue and Prominent Key Players to 2025 - News Times

DUBLIN, Feb. 14, 2020 /PRNewswire/ -- The "Postoperative Pain - Market Insights, Epidemiology and Market Forecast - 2028" report has been added to ResearchAndMarkets.com's offering.

The Postoperative Pain Report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Postoperative Pain in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom), and Japan.

The report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Postoperative Pain from 2017 to 2028 segmented by seven major markets. The report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.

Postoperative Pain Epidemiology

According to the review article by Tong J Gen (2017), surgery and anesthesia are critical health care services that reduce the risk of death and disability among millions worldwide each year, and the need for these services is expected to continue to increase over the next decade. Globally, nearly 313 million operations were performed in 2012. Although possibly life-saving, surgery is also related to potential harm, which normally includes pain during and after the procedure.

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology scenario of Postoperative Pain in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017-2028 for the following aspects:

The disease epidemiology covered in the report is segmented by:

As per the analysis, in 2017 the total number of incident cases of postoperative pain in the US was 40,314,731. The main reasons behind increased cases are due to increase morbidity, reduced physical function and quality of life, increased cost of care, bad recovery, preexisting pain, and prolonged opioid use during and after hospitalization.

Further, according to the publisher, in 2017, it is estimated that the severity-specific incident cases of postoperative pain in France were 1,194,644, 1,439,003 and 828,105 in mild, moderate and severe cases respectively. Additionally, Japan was observed with 12,134,677 incident cases for postoperative pain in 2017.

A study was conducted by Marinangeli et al. (2009) to know the treatment of acute pain in the prehospital emergency setting remains a significant problem. The study evaluated the incidence, site, and possible cause of acute pain in the prehospital period and also the current state of prehospital pain management by assessing analgesic availability in emergency vehicles in Italy. The study concluded that pain symptoms were present in approximately two-thirds of the patients (n = 383) and ranked as moderate to unbearable in 41.75%.

Results of the analgesic availability survey specify that 10.6% of the ambulance services carry no pain killers (including nonsteroidal anti-inflammatory drugs [NSAIDs] and/or paracetamol) and 11.5% are without an opioid. The pain evaluation was calculated which showed that 32.5% had no pain, 22% showed slight pain, 26.5% showed moderate pain, 12% patient felt severe pain, 3.25% patient could not bear the pain, and 3.75% patient were not defined in the scale (Marinangeli et al., 2009).

Postoperative Pain Drug Chapters

This segment of the Postoperative Pain report encloses a detailed analysis of the drugs that are expected to be launched in other regions. It also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Expected launch of potential therapies may increase the market size in the coming years, assisted by an increase in the prevalent population of Postoperative Pain and awareness of the disease. The overall dynamics of the Postoperative Pain market is anticipated to change in the coming years owing to the expected launch of emerging therapies that are already approved in specific regions but are expected to be launched in other regions as well. The major key players such as Heron Therapeutics, Cara Therapeutics, Trevena and others will significantly increase the market during the forecast period (2019-2028).

Postoperative Pain Market Outlook

Currently, the treatment pattern consists of different classes of drugs that are classified into pharmacologic and nonpharmacological therapies. The pharmacological therapies include analgesics that are further segregated into opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and acetaminophen respectively. The acute pain is also managed by the use of benzodiazepines, muscle relaxants, antidepressants, alpha-2 agonists, gamma-aminobutyric agonists, and cannabinoids.

Further, nonpharmacological therapies include acupuncture, psychological approaches (cognitive behavioral therapy, mindfulness-based stress reduction), chiropractic manipulation, physical therapy, transcutaneous electrical stimulation, massage therapy, exercise, and other complementary and alternative medicine therapies (CAM).

Opioids are a large group of pain-relieving drugs that are used for reducing the pain in the postoperative cases. These drugs majorly include fentanyl, hydromorphone, morphine, oxycodone, oxymorphone, and tramadol. Also, non-steroidal anti-inflammatory drugs (NSAIDs) are a sensible choice because of their effectiveness after surgical procedures. However, before surgeons start prescribing NSAIDs in place of opioids, it is crucial first to understand their potential post-surgical complications.

NSAIDs provide anti-inflammatory, antipyretic, analgesic and thrombotic effects through the inhibition of the enzymes cyclooxygenases 1 and 2 (COX-1 and COX-2). Although several generics are available for NSAIDs and presence of generics in the market is due to patent expiration. Paracetamol is the most commonly used analgesic with analgesic and antipyretic action. Even though it has been widely available for a long time, its exact mechanism of action is still unknown.

In addition to this, in September 2015, Zalviso was approved by the European Commission (EC) for the management of acute moderate-to-severe pain in adult patients in the hospital setting. The drug is a synthetic, potent opioid with highly selective binding to -opioid receptors. Another approved drug in the European Union is Maxigesic, which is approved in Austria, Belgium, Croatia, France, Germany, Luxembourg, Netherlands, Portugal, and Spain in May 2017. The drug reduces fever and provides temporary relief of pain associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, sore throat, arthritis, tennis elbow, period pain, muscular pain, rheumatic pain, aches and pains associated with colds and flu.

Dsuvia is an opioid agonist contains sufentanil and is indicated for use in adults in a certified medically supervised healthcare setting, such as hospitals, surgical centers, and emergency departments, for the management of acute pain. Dsuvia is administered in the form of the tablet sublingually to the patient. Also, it is approved as a brand name Dzuveo in Europe and is effective in reducing severe pain following surgeries.

The postoperative pain pipeline possesses potential drugs in late and mid developments to be launched in the near future. The major key players include Olinvo (Trevena), HTX-011 (Heron Therapeutics), and CR845/Difelikefalin (Cara Therapeutics).

Olinvo (Trevena) is a novel G protein biased (selective) mu-opioid receptor (MOR) ligand which is in development for the management of moderate-to-severe acute pain in hospitals or other controlled clinical settings where IV opioid therapy is warranted. The drug is currently in phase III clinical developmental trial.

Heron Therapeutics is developing a potent drug HTX-011 (bupivacaine and meloxicam) which is in phase III developmental trial. The drug is a fixed-dose combination of the local anesthetic bupivacaine with the nonsteroidal anti-inflammatory drug (NSAID) meloxicam. In December 2018, the US FDA accepted the new drug application (NDA) for HTX-011 and also granted a Priority Review designation.

This segment gives a thorough detail of market trend of each therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to the publisher, the market of Postoperative Pain in the 7MM is expected to change from 2019-2028.

Postoperative Pain Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2017-2028. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Approval of therapies for Postoperative Pain such as Maxigesic (AcelRx Pharmaceuticals; to be launched in US and Japan), HTX-011 (Heron Therapeutics; to be launched in US, EU and Japan), Olinvo (Trevena; to be launched in US, EU and Japan), CR845 (Cara Therapeutics; to be launched in US, EU and Japan), and other targeted therapies in the forecast period [2019-2028] will also create a positive impact on the Postoperative Pain market.

The market is anticipated to show an extensive boost due to projected label expansion of the current therapies and emergence of potential pipeline products as approved therapies in the near future. The market size of Postoperative in the seven major markets in 2017 was USD 1,067.82 Million in 2017. Japan accounts for the least market size in the 7MM during the forecast period 2017-2028, at a CAGR of 7.41% for the study period (2017-2028). Among the EU5 countries, Germany had the highest market size with USD 49.89 Million in 2017, while Spain had the lowest market size of postoperative pain.

Report Insights

Key Strengths

Report Assessment

Key Benefits

Companies Mentioned

Key Topics Covered

1. Key Insights

2. Postoperative Pain Market Overview at a Glance2.1. Market Share (%) Distribution of Postoperative Pain in 20172.2. Market Share (%) Distribution of Postoperative Pain in 2028

3. Disease Background and Overview: Postoperative Pain3.1. Introduction3.2. Transition from Acute to Chronic Pain3.2.1. Elective or Planned Procedures3.2.2. Common Types of Acute Postoperative Pains3.3. Pathophysiology of Acute Pain3.3.1. Formation of reflexes in postoperative pain3.3.2. Negative effects of postoperative pain on various organ systems3.3.3. Psychological effects of postoperative pain3.3.4. Late effects of insufficient postoperative analgesia3.3.5. Chronic postoperative pain3.4. Factors affecting postoperative pain3.5. Diagnosis of Postoperative Pain3.5.1. Medical history, physical examination, and specific evaluation of pain3.5.2. Measuring pain3.5.3. Various Grading Scales used for Diagnosis of Acute Pain3.5.4. Verbal methods of pain assessment3.5.5. Multidimensional methods of pain assessment3.5.6. Nonverbal methods of pain assessment3.6. Diagnostic Algorithm3.7. Guidelines3.7.1. Guidelines on the Management of Postoperative Pain3.7.2. Goals and Elements of the Initial Assessment

4. Epidemiology and Patient Population4.1. Key Findings4.2. Total number of Incident cases of Postoperative Pain in the 7MM

5. Epidemiology of Postoperative Pain in the 7MM5.1. Assumptions and Rationale5.2. United States5.2.1. Total number of surgical procedures in the US5.2.2. Total number of Postoperative Pain Incident cases in the US5.2.3. Severity-specific Postoperative Pain incident cases in the US5.3. Germany5.4. France5.5. Italy5.6. Spain5.7. United Kingdom5.8. Japan

6. Treatment6.1.1. Pharmacological Therapies6.1.2. Multimodal analgesia6.1.3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)6.1.4. Opioids6.1.5. Non-opioid analgesics6.1.6. Procedure-specific analgesia6.1.7. Regional anesthesia6.1.8. Non-Pharmacological Methods to Treat Acute Pain6.1.9. Physical methods6.1.10. Intravenous Patient-Controlled Analgesia (PCA)6.1.11. Nerve Blocks6.1.12. Pediatric Pain Management6.2. Treatment Algorithm for Acute Postoperative Pain

7. Guidelines for Acute Pain7.1.1. Recent advances in acute pain management: understanding the mechanisms of acute pain, the prescription of opioids, and the role of multimodal pain therapy (2017)7.1.2. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council (2017)

8. Unmet Needs

9. Marketed Drugs9.1. Marketed Drugs Key-cross Competition9.2. Zalviso: AcelRx Pharmaceuticals9.2.1. Product Description9.2.2. Regulatory Milestones9.2.3. Other Developmental activities9.2.4. Clinical Development9.2.5. Safety and Efficacy9.2.6. Product Profile9.3. Maxigesic: AFT Pharmaceuticals9.4. Dsuvia/Dzuveo (Sufentanil): AcelRx Pharmaceuticals9.5. Dexketoprofen Tramadol: Menarini Group

10. Emerging Drugs10.1. Key Cross Competition10.2. Olinvo (Oliceridine injection or TRV130): Trevena10.2.1. Product Description10.2.2. Other Development Activities10.2.3. Clinical Development10.2.4. Safety and Efficacy10.2.5. Product Profile10.3. HTX-011: Heron Therapeutics10.4. CR845/Difelikefalin: Cara Therapeutics10.5. NTM-001: Neumentum Pharmaceuticals10.6. PF-05089771: Pfizer

11. Postoperative Pain: 7 Major Market Analysis11.1. Key Findings11.2. Forecasting Parameters11.3. Market Size of Postoperative Pain in the 7MM Countries

12. 7MM Market Outlook12.1. Expected Approval: Emerging Therapies12.2. United States12.2.1. Total Market size of Postoperative Pain12.2.2. Market Size by Therapies12.3. Germany12.4. France12.5. Italy12.6. Spain12.7. United Kingdom12.8. Japan Market Size

13. Market Drivers

14. Market Barriers

For more information about this report visit https://www.researchandmarkets.com/r/ita38l

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Read more:

Postoperative Pain Industry Outlook, 2020-2028 - Approval of Therapies such as Maxigesic, HTX-011, Olinvo, CR845 Will Create a Positive Impact on the...

Propolis Market: An Overview

The propolis market is expected to witness robust growth during 2018-2026. Propolis is a drug on the rise for a wide variety of assumed and proven benefits. Propolis embeds a special compound called pinocembrin. This flavonoid works as an antifungal with its anti-inflammatory properties and antimicrobial properties. The medicine is widely used for its ability to help heal major wounds. Studies continue to support the use of propolis to treat severe burn victims. The drug also trends popularly, thanks to its mythical properties arising from folk lore. Many people also believe it is helpful in curing cancer. While these beliefs are not yet confirmed with research, both the beliefs and actual benefits continue to drive significant growth for the propolis market.

Download Brochure of This Market Report at https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6079

Propolis Market: Notable Developments

Wedderspoon, one of the largest honey brand in the United States has launched a new line of Propolis products. These health honey products are throat sprays are a new line of natural products which are rising in demand worldwide. The sprays are touted as functional well product lines. These sprays are marketed as soothing for throats, and supportive to growth of the immune system. The rising health consciousness, and rising demand for natural products like these are expected to create major opportunities for players in the propolis market in the near future.

An international team of researchers have made a significant discovery that can change the fortunes of several players in the propolis market in the near future. These researchers have found that adding 4kg-1 to the diets of fishes resulted in best survival rates in cold climatic conditions. This study published in Aquculture journal was conducted by researchers from the National institute of Ocanography and Fisheries.

The study experimented with Nile Tilapia fish. The rising demand for fish products, and growing threats of extinctions to various fish species is a major concern for the fishing industry worldwide. This study and potential of propolis use in the industry is a major potential upturn for the propolis market.

The Global Propolis Market: Drivers and Restraints

The global propolis market is expected to witness robust growth in the near future, thanks to rising demand for alternative medicine, growing demand for natural food products, and increased reliance on the substance for a wide variety of medical needs. The rising cases of burn victims due to rising instances of forest fires and urban fire outbreaks are also a major factor boosting demand in the propolis market. The demand from the healthcare sector for treating severe burn wounds is likely to rise in the near future. Additionally, propolis is also used for a variety of common conditions like treating sore throats, soothing voice chords, etc. The increasing reliance, the cost-effectiveness of alternative treatments, and increasing move by patients to prefer alternative healthcare options at retail clinics are expected to remain major drivers of growth.

The Global Propolis Market: Geographical Analysis

The global propolis market is expected to witness major growth in North America region. The growing demand for alternative medicine, growing demand for natural food products, and increasing awareness of the substance are expected to drive significant growth. The propolis market is also expected to register significant growth in Asia Pacific region. The significant rise in disposable incomes, large population, and traditional use of propolis in medicine are expected to register significant growth for the market in the region.

Request For TOC On this Market Report at https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6079

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Read more:

Propolis Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2028 - Redhill Local Councillors

As more and more states legalize marijuana, more and more people are using it. Use in pregnant women and women who breastfeed is also on the rise. This can be concerning since studies have demonstrated daily cannabis use during pregnancy can be harmful. For example, studies have established a low birth weight with use. Tetrahydrocannabinol (THC) is the main psychoactive component of cannabis. THC is able to cross the placenta during pregnancy as well as pass through breast milk during feeding.

A study published in the Journal of Addiction Medicine evaluated the perceptions of cannabis use in pregnancy and breastfeeding. This study was the first to evaluate perceptions from the patients perspectives as well as being conducted in a state with legal recreational cannabis use. The investigators interviewed 19 women in Washington state, 14 were pregnant and five were postpartum. All 19 women used cannabis on a daily basis or occasionally.

The researchers found five common themes among the women interviewed. First, some women stated they used cannabis to control other conditions such as anxiety, nausea, pain, and stress. For example, one woman stated it allowed her to keep food down during pregnancy. Women also expressed concern for their baby.

Second, women were evaluating the need for cannabis throughout their stages of pregnancy and believed it was safer than alternative prescription drugs.

Third, women were receiving mixed messages from their providers. Some providers told them to stop, some asked them to cut back on use, while others didnt address the topic at all when it was brought up by the patient.

Fourth, women wanted more information regarding the safety and concerns of daily cannabis use during pregnancy.

Fifth, some women were concerned about being drug tested and potential consequences from child protective services.

This study is unique in that it gives insight to patients perspectives, which is vital when providers evaluate patients needs and concerns. The researchers recommend a harm reduction approach, which suggests cutting back on cannabis use compared to the cold turkey alternative. It is also important that national guidelines are followed by providers, which state that risks of cannabis use during pregnancy and postpartum should be explained to patients. It is important to engage in shared decision-making while decreasing stigma.

Written by Kayla Dillon, BS

References:

Image byBoris GonzalezfromPixabay

See the article here:

Perceptions of daily cannabis use during pregnancy - Medical News Bulletin

In Gwyneth Paltrows new Netflix series, The Goop Lab, Paltrow explores a variety of wellness management approaches, from energy healing to psychedelic psychotherapy.

Goop has long been criticised for making unsubstantiated health claims and advancing pseudoscience, but the brand is incredibly popular. It was valued at over US$250 million (A$370 million) in 2019.

The alternative health industry is worth A$4.1 billion in Australia alone and projected to grow.

A key driver of the industry is increased health consciousness. With easier access to information, better health literacy, and open minds, consumers are increasingly seeking alternatives to managing their well-being.

Goop has capitalised on the rise in popularity of alternative health therapies treatments not commonly practised under mainstream Western medicine.

Health systems in countries such as Australia are based on Western medicine, eschewing traditional and indigenous practices. These Western systems operate on measurable and objective indicators of health and well-being, ignoring the fact subjective assessments such as job satisfaction and life contentment are just as important in evaluating quality of life.

This gap between objective measures and subjective assessments creates a gap in the marketplace brands can capitalise on not always for the benefit of the consumer.

The Goop Lab fails to engage with the cultural heritage of traditional health and well-being practices in any meaningful way, missing an important opportunity to forward the holistic health cause.

Read more: Gwyneth Paltrow's new Goop Lab is an infomercial for her pseudoscience business

The uncritical manner in which these therapies are presented, failure to attribute their traditional origins, absence of fact-checking, and lack of balanced representation of the arguments for and against these therapies only serve to set back the wellness cause.

Many of the historical and cultural origins of the therapies in The Goop Lab are not investigated, effectively whitewashing them.

The first episode, The Healing Trip, explores psychedelic psychotherapy, suggesting this is a new and novel approach to managing mental health.

In reality, psychedelics have been used in non-Western cultures for thousands of years, only recently enjoying a re-emergence in the Western world.

In the second episode, Cold Comfort, the Wim Hof Method (breathing techniques and cold therapy) is also marketed as a novel therapy.

The meditation component of Hofs method ignores its Hindu origins, documented in the Vedas from around 1500 BCE. The breathing component closely resembles pryma, a yogic breathing practice. The Hof dance looks a lot like tai chi, an ancient Chinese movement practice.

Whitewashing these alternative therapies represents a form of colonisation and commodification of non-Western practices that have existed for centuries.

The experts showcased are usually white and from Western cultures, rather than people of the cultures and ethnicities practising these therapies as part of their centuries-old traditions.

Rather than accessing these therapies from authentic, original sources, often the consumers only option is to turn to Western purveyors. Like Paltrow, these purveyors are business people capitalising on consumers desire and pursuit of wellness.

Paltrow describes Goop as a resource to help people optimise the self. But many of these therapies are economically inaccessible.

In The Health-Span Plan, Paltrow undergoes the five-day Fast Mimicking Diet by ProLon a diet designed to reap the health benefits of fasting while extremely restricting calories. The food for the treatment period costs US$249 (A$368) (but shipping is free!). The average Australian household spends just over A$250 on groceries weekly.

Paltrow also undergoes a vampire facial, where platelet-rich plasma extracted from your own blood is applied to your skin. This facial is available at one Sydney skin clinic for between A$550 and A$1,499.

These therapies commodify wellness and health as a luxury product, implying only the wealthy deserve to live well, and longer.

This sits in stark odds with the goals of the World Health Organisation, which views health as a fundamental human right without distinction of race, religion, political belief, economic, or social condition.

Companies like Goop have a responsibility to explain the science and the origins of the methods they explore.

Given their profit-driven motive, many absolve themselves of this responsibility with an easy disclaimer their content is intended to entertain and inform not provide medical advice. This pushes the burden of critically researching these therapies onto the consumer.

Governments should seek to fund public health systems, such as Medicare, to integrate traditional health practices from other cultures through consultation and working in collaboration with those cultures.

Read more: Traditional medicines must be integrated into health care for culturally diverse groups

Perhaps this will give everyone access to a wellness system to help us live well, longer. This way, citizens are less likely to be driven towards opportunists such as Goop seeking to capitalise on our fundamental human right to live well.

Continued here:

Marketing, not medicine: Gwyneth Paltrows The Goop Lab whitewashes traditional health therapies for profit - The Conversation AU

Allow author Deepak Chopra to teach you the seven spiritual laws of big fit success:

The Law of Pure Sneaker Potentiality: let your loud sneakers do the talking. Don't force the rest of your fit to compete with them. Let them simply BE.

The Law of Giving: let a simple and harmonious outfitred trim on a jacket picking up the vivid splash of your red sneakersbe a present to the world

The Law of Karma: each accessory will generate a force of energy that returns to the entire outfit. Good glasses make for good fits.

The Law of Least Effort: let a statement staple, like a velvet, mandarin collar jacket, do most of the leg work.

The Law of Intention and Desire: make a list of clothes you want, but find ways to bring these ideas to fruition using the contents you already possess.

The Law of Detachment: Not every piece has to be a showstopper. Sometimes black pants are just what the alternative-medicine healer ordered.

The Law of Dharma: We get dressed to fulfill a purpose.

Here is the original post:

Deepak Chopra Has Mastered the Seven Spiritual Laws of Big Fit Success - GQ

MY WAR CRIMINAL

Personal Encounters With an Architect of Genocide

By Jessica Stern

Where do malevolent leaders come from? What drives them, and why do people follow them? The rise of populist demagogues around the world, from Hungarys Viktor Orban, Turkeys Recep Tayyip Erdogan and Russias Vladimir Putin to our own Donald Trump, has given these perennial questions new salience. In My War Criminal: Personal Encounters With an Architect of Genocide, the counterterrorism expert Jessica Stern seeks an answer from one of those leaders himself: Radovan Karadzic, the Bosnian Serb strongman implicated in atrocities committed during the ethnic cleansing of Bosnian Croats and Muslims between 1992 and 1995, including the deadly four-year siege of Sarajevo and the murder of thousands of Muslim men and boys at Srebrenica. Indicted by the International Criminal Tribunal for the Former Yugoslavia (ICTY) in 1995, Karadzic, a trained physician, changed his name and, disguised as a practitioner of alternative medicine, managed to evade capture for over a decade. In 2008, he was finally arrested in Belgrade, Serbia, and sent to The Hague to stand trial before the ICTY, which in 2016 convicted him of war crimes, crimes against humanity and genocide (his conviction was recently confirmed on appeal).

Stern, who has made a practice of speaking with terrorists of various stripes in order to understand their motivations, sought and exceptionally, as such requests are usually denied received permission to visit Karadzic from 2014 to 2016 in his jail in The Hague. In My War Criminal, she interweaves excerpts from their conversations with explanations of the history of the Bosnian war and reflections on the influences that shaped Karadzic. As the title of the book suggests, Stern also sees herself as part of the narrative, frequently calling attention to her own responses to her war criminals statements and behavior.

Understandably skeptical of Karadzics self-serving answers to probing questions, but determined to make a fair attempt to understand him, Stern goes in search of his family members, friends and former colleagues. From her interviews, and from her investigations into Serbian history and culture, she is surprised to find some truth in Karadzics claims. His insistence that Serbs were merely defending themselves against external threats, she observes, is rooted in memories of actual historical wounds that continue to exert a powerful influence. Karadzic writes poetry, and Stern explores the Serbian tradition of epic poetry and music that glorifies historical victimhood and martyrdom, and formed a backdrop to his youth.

Stern quotes extensively from the large body of literature on the former Yugoslavia, and also explores such related topics as the legal definition of genocide, the international law on secession, the complexities of globalization and the new man that Communism hoped to create. These citations and digressions, often in lengthy footnotes, can lend the book the feel of a graduate school thesis, and some errors and false impressions creep in: a misleading suggestion that the ICTY one-sidedly prosecuted only Serbs (it did not); the mistaken characterization of a Serbian case against Croatia at the International Court of Justice as involving World War II rather than the more recent conflicts; the incorrect claim that the indictments of Karadzic and his notorious general Ratko Mladic were the first to be handed down by the ICTY. In an effort to be evenhanded and to consider all sides in the conflict (and perhaps because of her own expertise), Stern devotes more space than may be warranted to the question of the influence of fundamentalist jihadis on the (traditionally quite secular) Bosnian Muslim population. Despite interventions during the war by several Muslim countries, she rightly concludes, the fears raised by Serbian propaganda regarding an Islamic fundamentalist takeover were considerably overblown.

View original post here:

Conversations With a Mass Murderer - The New York Times

WHO/Europe is pleased to release details of the 2020 Culture and Health webinar series. For the second year running, the series shines a spotlight on the cultural contexts of contemporary health challenges.

Featuring speakers from a variety of backgrounds including policy-makers, historians and people with lived experience the 2020 series will examine topics such as the rise of vaccine hesitancy, the digital footprint on health equity, the homecoming of traditional childbirth, and the mental health and well-being of youth in the Sustainable Development Goals (SDGs) era.

In addition to having a live audience, each webinar will be webcast and participants will be invited to tune in online and ask questions in real time.

The series is a collaboration between WHOs Cultural Contexts of Health and Well-being (CCH) project, the Centre for Global Health Histories at University of York, and the Wellcome Centre for Culture and Environments of Health at the University of Exeter. The Culture and Health webinar series is generously supported by the Wellcome Trust.

Join us for the first webinar of the year: What works? Complementary and alternative medicines in the biomedical world.

The use of complementary and alternative medicines, such as acupuncture and chiropractic treatment, is growing rapidly. However, there are still many obstacles to their integration into standard health services. How do cultural differences, prejudices and the history of medicine play a role in these practices and their acceptance? And how do we draw the line between what works and what doesn't?

The webinar will take place at the University of York on Thursday, 6 February 2020 at 13:0014:00 CET (12:0013:00 GMT). To join the conversation and watch the event live, please visit the webinar page.

Here is the original post:

Data and evidence - Launching the 2020 Culture and Health webinar Series - World Health Organization

The Centers for Medicare & Medicaid Services (CMS) has announced that Medicare will now cover acupuncture for patients with chronic low back pain in part because of the widespread abuse of opioids in America. Medicare will now cover up to 12 sessions in 90 days with an additional 8 sessions for those patients with chronic low back pain who demonstrate improvement. Until now, acupuncture was not covered by Medicare.

Getty

Expanding options for pain treatment is a key piece of the Trump Administrations strategy for defeating our countrys opioid crisis, US Department of Health and Human Services (HHS) Secretary Alex Azar said in a statement. President Trump has promised to protect and improve Medicare for our seniors, and deciding to cover this new treatment option is another sign of that commitment. Medicare beneficiaries will now have a new option at their disposal to help them deal with chronic low back pain, which is a common and sometimes debilitating condition.

A federal agencyin the HHS, CMSadministers the Medicare program and works in partnership with stategovernments to administer Medicaid, the Children's Health InsuranceProgram (CHIP), and health insurance portability standards.

We are dedicated to increasing access to alternatives to prescription opioids and believe that covering acupuncture for chronic low back pain is in the best interest of Medicare patients, said CMS Principal Deputy Administrator of Operations and Policy Kimberly Brandt in a statement. We are building on important lessons learned from the private sector in this critical aspect of patient care. Over-reliance on opioids for people with chronic pain is one of the factors that led to the crisis, so it is vital that we offer a range of treatment options for our beneficiaries.

The CMS announced this week that its decision to cover acupuncture was the result of an examination of coverage policies of private payers and takes into account an assessment of benefits and harms and the opioid public health crisis. And while there is variation in whats covered and the allowed number of visits to acupuncturists among private payers, a large number of them provide some coverage of acupuncture, CMS reported.

While a small number of adults 65 years of age or older have been enrolled in published acupuncture studies, patients with chronic low back pain in these studies showed improvements in function and pain. The evidence reviewed for this decision supports clinical strategies that include non-pharmacologic therapies for chronic low back pain, CMS reported.

Some 47,600 deaths related to overdose involved opioids in 2017, the CMS reported. The CMS said it is now keenly focused on fighting the opioids epidemic including by supporting access to pain management using a safe and effective range of treatment options that rely less on prescription opioids.

The CMS said it has made significant strides in preventing opioid use disorder by, for example, issuing safety alerts to pharmacists when a beneficiarys opioids prescription exceeds certain levels. Given these and other efforts from federal partners, total opioids dispensed by pharmacies nationwide declined 31 percent since 2017, CMS reported.

Practitioners of acupuncturea form of alternative medicine and a key component of traditional Chinese medicinestimulate strategic points on the body, most often by inserting thin needles through the skin. The alternative therapy is most commonly used to treat pain but is increasingly being used for overall wellness and stress management.

According to Mayo Clinic, traditional Chinese medicine explains acupuncture as a technique for balancing the flow of energy or life forceknown as chi or qi (chee)believed to flow through pathways (meridians) in your body. By inserting needles into specific points along these meridians, acupuncture practitioners believe that your energy flow will re-balance. In contrast, many Western practitioners view the acupuncture points as places to stimulate nerves, muscles and connective tissue. Some believe that this stimulation boosts your body's natural painkillers.

Whatever the reason, reviews on its effectiveness are also mixed, and many want even more alternative therapies covered.

To me, the best therapy is chiropractic and massage therapy, said Bonnie Huffman. Massage therapy should be covered. The benefits of it are remarkable. I have had successful back surgery, and I would not be working if it wasnt for my chiropractor and massage therapist. I have tried the needles. They dont work for me, but I know people that they do work for.

I tried [acupuncture] once on the reference of a pain management doctor to a physical therapist, said Lois Martin. She hit a nerve, and that did not feel good at all. Couldnt tell any difference even after the treatment. She was young and may have been inexperienced. Chiropractic has given best results. Massage therapy would be awesome but its expensive and not covered. I think it would speed up recovery after a flair up.

Currently, Medicare only covers chiropractic care as a treatment for a condition called spinal subluxation. According to the latest information regarding Medicare coverage in 2020 from AARP, original Medicare pays for only one chiropractic service: manual manipulation of the spine if deemed medically necessary to correct a subluxation (when one or more of the bones in your spine are out of position). This procedure, when performed by a chiropractor or other qualified provider, is covered throughMedicare Part B, the component of original Medicare that includes outpatient services.

Medicare will pay 80% of the Medicare-approved rate for this procedure, and you will owe 20% of the amount. In addition, you must also pay your deductible for Part B before Medicare begins to pay its share. You pay all the costs for other services provided or tests that a chiropractor orders, includingmassage therapy and X-rays. Medicare will cover the cost of an X-ray a physician orders to demonstrate that a spinal subluxation requires treatment but will not if a chiropractor ordered the X-ray. SomeMedicare Advantageplans do offer routine chiropractic services, however, as an additional benefit.

According to Mayo Clinic, acupuncture has been used to relieve discomfort associated with a variety of diseases and conditions, including:

The risks of acupuncture are low as long as patients seek a competent, certified acupuncture practitioner who uses sterile, one-time use needles. Common side effects could include soreness and minor bruising or bleeding at the site where the needles were inserted.

Still Mayo Clinic cautions that not everyone is a good candidate for acupuncture. You may be at risk of complications if you:

Mayo Clinic recommends taking the same steps in choosing an acupuncturist that you would if you were choosing a new doctor:

And not everyone responds to acupuncture.

Many people who have chronic low back pain have found acupuncture to be helpful. But the scientific evidence to support these claims has been mixed, partly because it can be difficult to devise a good form of sham acupuncture for comparison, said Brent A. Bauer, M.D.

According to the National Center for Commentary and Integrative Health (NCCIH), several studies indicate that both traditional (actual) and simulated (sham/placebo) acupuncture decrease pain, but other studies have suggested that the neural mechanisms involved may be different. (Simulated acupuncture mimics actual acupuncture, but without piercing the skin or using specific points.) There is evidence that simulated acupuncture appears to work just as well as real acupuncture. Evidence also shows that acupuncture works best in people who expect it to work.

Scientific studies have indicated that sham acupuncture works just as well as real acupuncture for back pain, Bauer said. This could mean that sham acupuncturecould be having an effect, or it could mean that the effects of acupuncture may be due in part to a placebo effect.

Bauer said the research on acupuncture is growing, but interpreting it is still a challenge. For now, most studies seem to indicate that, for most people, acupuncture results in some beneficial effect with a low risk of side effects when provided by a well-trained practitioner. So if other treatments haven't helped your low back pain, it may be worth trying acupuncture. But if your back pain doesn't begin to improve within a few weeks, acupuncture may not be the right treatment for you.

Mayo Clinic has ongoing studiestesting treatments for pain management, including acupuncture.

For the purpose of the CMS decision, chronic low back pain is defined as:

Physician assistants, nurse practitioners/clinical nurse specialists and auxiliary personnel may furnish acupuncture if they meet all applicable state requirements and have:

Read more:

Medicare Will Now Pay For Acupuncture In Part Due To Opioid Abuse - Forbes

News

With offerings from reiki to massage to intuitive tarot readings, the new spot is perfect for the mystical among us.

Photograph by Amber Johnson, courtesy of The Reiki School

Get ready to relax and breathe deeper in Queen Village at the just-opened outpost of The Reiki School + Clinic. Its the 21-year-old businesss second Philadelphia location (934 E. Moyamensing Street.) With two treatment rooms, a store, and a classroom, the Queen Village spot which had its grand opening earlier this month offers the schools full range of alternative healing therapies, from reiki to massage to herbal consultations to intuitive tarot readings.

For those of you wondering what exactly Reiki is, we can explain its a Japanese energy healing method. When you go in for your Reiki session, the practitioner places their hands lightly on your body as you recline, fully clothed, on a comfy massage chair or table. This purportedly allows for a transfer of healing energy. Yep, its as simple (or complicated) as that: Reiki is all about balance and a belief in that transfer of energy.

Unlike some types of massage or physical therapy, Reiki doesnt focus on treating specific symptoms alone. Instead, treatments at the Reiki School + Clinic set out to offer the entire body a sense of wellbeing and peace whether it works or not is a matter of individual assessment.

Photograph by Amber Johnson, courtesy of The Reiki School

If Reiki is still a little too woo-woo for you to book a full session, the Reiki School + Clinic offers combo massage and Reiki treatments at both of their Philly locations, with added special options for pre-and-post-natal clients. (The first outpost is The Ellington Building on 1500 Chestnut Street.)

But for those who want even more mystical healing?The School also offers sound healing options for Reiki treatments involving quartz crystal singing bowls, drums, rattles, and crystals placed on your body. They also offer space cleansing services for homes and offices, herbal medicine consultations, and tarot readings for guidance on everything from your love life to your work life to your past life.

Photograph courtesy of The Reiki School

Photograph courtesy of The Reiki School

At a minimum of $80 per session, you might want to learn how to perform Reiki for yourself at home. If youre intrigued, you can even take classes at the Reiki School + Clinic to learn how to treat yourself or others. The Reiki School + Clinic also offers classes in Reiki at four different levels, so that you too can become a master of the treatment method. They even have options for training in Animal Reiki, because we all know our furry friends (and bugs?) need balance too.

Even if Reiki isnt for you, the new location is good news for Queen Village. Reiki School Co-directors Stephanie Palmer, LMT, RM, and Vicki Zaharopoulos, LMT, RM, HHC bring years of expertise and a desire to be a positive presence in the neighborhood. The Schools mission is even based around mirroring the community of bees in a hive (check out their honeycomb logo). They work to support their communities and neighborhoods by collaborating with local healthcare groups and nonprofits at their two Philly locations.

So what does it mean that a holistic, Japanese wellness-based business is expanding (to its third location!) in our area? Maybe its part of the unstoppable millennial interest in astrology and other forms of alternative spirituality. Or maybe its a sign that Philadelphia has a growing need for balance and mental clarity these days (A.K.A. Were all way too stressed out.)

Either way, be sure to check out the new location of the Reiki School + Clinic, and treat yourself to a day or several of pursuing inner peace.

Want to hear more from us? Join Be Well Philly at:FACEBOOK|INSTAGRAM|NEWSLETTER|TWITTER

Link:

A New Location of the Reiki School Just Opened in Queen Village - Philadelphia magazine